Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.65 -0.30 (-1.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ultragenyx Pharmaceutical (RARE) Sale and Maturity of Investments (2013 - 2026)

Updated

Analysis

Ultragenyx Pharmaceutical (RARE) Sale and Maturity of Investments (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Ultragenyx Pharmaceutical 1.54 Bn -260.16 Mn 180.00 Mn 67.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 67.00 Mn
Mar 31, 2026 88.00 Mn
Dec 31, 2025 81.97 Mn
Sep 30, 2025 136.03 Mn
Jun 30, 2025 88.91 Mn
Mar 31, 2025 137.09 Mn
Dec 31, 2024 119.18 Mn
Sep 30, 2024 93.70 Mn
Jun 30, 2024 68.49 Mn
Mar 31, 2024 131.64 Mn
Dec 31, 2023 117.25 Mn
Sep 30, 2023 207.90 Mn
Jun 30, 2023 219.54 Mn
Mar 31, 2023 202.31 Mn
Dec 31, 2022 54.18 Mn
Sep 30, 2022 150.64 Mn
Jun 30, 2022 111.84 Mn
Mar 31, 2022 228.41 Mn
Dec 31, 2021 180.34 Mn
Sep 30, 2021 190.15 Mn
API Access

Ultragenyx Pharmaceutical Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RARE&period=max&api_key=YOUR_API_KEY